BlackRock
PJP icon

BlackRock’s Invesco Pharmaceuticals ETF PJP Stock Holding History

BlackRock’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.2K Hold
230
– – ﹤0.01% 5307
2026
Q1 		$23.9K Sell
230
-3,470
-94% -$367K ﹤0.01% 5275
2025
Q4 		$387K Buy
+3,700
New +$372K ﹤0.01% 4551
2016
Q1 		– Sell
-50
Closed -$3K – 3729
2015
Q4 		$3K Buy
+50
New +$3.54K ﹤0.01% 3264

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MML Investors Services
MML Investors Services Springfield, Massachusetts $49B AUM 25.55% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
JGCM
Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

BlackRock's PJP Position: Q2 2026 in Review

BlackRock held its Invesco Pharmaceuticals ETF (PJP) position steady in Q2 2026 at 230 shares worth $27.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5307.

BlackRock first reported a position in PJP in Q4 2015 and has held it in 4 quarters since. The position peaked at $387K in Q4 2025. 117 funds tracked by Wall St. Rank hold PJP as of Q2 2026.

  • BlackRock held 230 shares of Invesco Pharmaceuticals ETF worth $27.2K as of Q2 2026.
  • BlackRock left its Invesco Pharmaceuticals ETF share count unchanged in Q2 2026.
  • Invesco Pharmaceuticals ETF made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5307 holding.
  • BlackRock first reported a position in Invesco Pharmaceuticals ETF in Q4 2015 and has held it in 4 quarters since.
  • BlackRock's Invesco Pharmaceuticals ETF position peaked at $387K in Q4 2025.
  • 117 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.